Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

226 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Spanish consensus on the physical health of patients with depressive disorders.
Giner J, Saiz Ruiz J, Bobes J, Zamorano E, López F, Hernando T, Rico-Villademoros F, Álamo C, Cervilla JA, Ibáñez Cuadrado Á, Ibáñez Guerra E, López S, Morán P, Palao DJ, Romacho M; Development Group Recommendations on Physical Health in Patients with Depression. Giner J, et al. Among authors: saiz ruiz j. Rev Psiquiatr Salud Ment. 2014 Oct-Dec;7(4):195-207. doi: 10.1016/j.rpsm.2014.05.003. Epub 2014 Jul 30. Rev Psiquiatr Salud Ment. 2014. PMID: 25087131 English, Spanish.
Verbal memory as a mediator in the relationship between subthreshold depressive symptoms and functional outcome in bipolar disorder.
Bonnín Cdel M, González-Pinto A, Solé B, Reinares M, González-Ortega I, Alberich S, Crespo JM, Salamero M, Vieta E, Martínez-Arán A, Torrent C; CIBERSAM Functional Remediation Group. Bonnín Cdel M, et al. J Affect Disord. 2014 May;160:50-4. doi: 10.1016/j.jad.2014.02.034. Epub 2014 Mar 11. J Affect Disord. 2014. PMID: 24709022
Functional remediation for patients with bipolar II disorder: improvement of functioning and subsyndromal symptoms.
Solé B, Bonnin CM, Mayoral M, Amann BL, Torres I, González-Pinto A, Jimenez E, Crespo JM, Colom F, Tabarés-Seisdedos R, Reinares M, Ayuso-Mateos JL, Soria S, Garcia-Portilla MP, Ibañez Á, Vieta E, Martinez-Aran A, Torrent C; CIBERSAM Functional Remediation Group. Solé B, et al. Eur Neuropsychopharmacol. 2015 Feb;25(2):257-64. doi: 10.1016/j.euroneuro.2014.05.010. Epub 2014 May 20. Eur Neuropsychopharmacol. 2015. PMID: 24906790 Clinical Trial.
Functional remediation in bipolar disorder: 1-year follow-up of neurocognitive and functional outcome.
Bonnin CM, Torrent C, Arango C, Amann BL, Solé B, González-Pinto A, Crespo JM, Tabarés-Seisdedos R, Reinares M, Ayuso-Mateos JL, García-Portilla MP, Ibañez Á, Salamero M, Vieta E, Martinez-Aran A; CIBERSAM Functional Remediation Group. Bonnin CM, et al. Br J Psychiatry. 2016 Jan;208(1):87-93. doi: 10.1192/bjp.bp.114.162123. Epub 2015 Nov 5. Br J Psychiatry. 2016. PMID: 26541692 Clinical Trial.
Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study.
Amoretti S, Mezquida G, Verdolini N, Bioque M, Sánchez-Torres AM, Pina-Camacho L, Zorrilla I, Trabsa A, Rodriguez-Jimenez R, Corripio I, Sarró S, Ibañez A, Usall J, Segarra R, Vieta E, Roberto N, Ramos-Quiroga JA, Tortorella A, Menculini G, Cuesta MJ, Parellada M, González-Pinto A, Berrocoso E, Bernardo M; 2EPs Group; Annex. Members of the 2EPs group. Amoretti S, et al. Span J Psychiatry Ment Health. 2023 Sep 14:S2950-2853(23)00010-8. doi: 10.1016/j.sjpmh.2023.04.001. Online ahead of print. Span J Psychiatry Ment Health. 2023. PMID: 38591832 Free article.
Double-blind, placebo-controlled study of the efficacy of reboxetine and citalopram as adjuncts to atypical antipsychotics for negative symptoms of schizophrenia.
Usall J, López-Carrilero R, Iniesta R, Roca M, Caballero M, Rodriguez-Jimenez R, Oliveira C, Bernardo M, Corripio I, Sindreu SD, González Piqueras JC, Felipe AE, Fernandez de Corres B, Ibáñez A, Huerta R; Abordaje Síntomas Negativos Esquizofrenia Group. Usall J, et al. J Clin Psychiatry. 2014 Jun;75(6):608-15. doi: 10.4088/JCP.13m08551. J Clin Psychiatry. 2014. PMID: 25004184 Clinical Trial.
The polygenic basis of relapse after a first episode of schizophrenia.
Segura ÀG, Prohens L, Gassó P, Rodríguez N, Garcia-Rizo C, Moreno-Izco L, Andreu-Bernabeu Á, Zorrilla I, Mane A, Rodriguez-Jimenez R, Roldán A, Sarró S, Ibáñez Á, Usall J, Sáiz PA, Cuesta MJ, Parellada M, González-Pinto A, Berrocoso E, Bernardo M, Mas S, Mezquida G, Arbelo N, De Matteis M, Galvañ J, Duque Guerra A, Arias I Queralt L, Perez-Bacigalupe M, Gonzalez-Ortega I, Toll A, Casanovas F, Sanchez-Pastor L, Valtueña M, Pomarol-Clotet E, García-León MÁ, Butjosa A, Rubio-Abadal E, Ribeiro M, López-Ilundain JM, Saiz-Ruiz J, León-Quismondo L, Rivero O, Ruiz P, Echevarría RS, García-Portilla MP. Segura ÀG, et al. Among authors: saiz ruiz j. Eur Neuropsychopharmacol. 2023 Oct;75:80-92. doi: 10.1016/j.euroneuro.2023.06.003. Epub 2023 Aug 19. Eur Neuropsychopharmacol. 2023. PMID: 37603902 Free article.
Exploration of cannabis use and polygenic risk scores on the psychotic symptom progression of a FEP cohort.
Segura AG, Mané A, Prohens L, Rodriguez N, Mezquida G, Cuesta MJ, Vieta E, Amoretti S, Lobo A, González-Pinto A, Diaz-Caneja CM, Bejarano AR, Jimenez E, Baeza I, Legido T, Saiz-Ruiz J, Bernardo M, Mas S; PEPs Group. Segura AG, et al. Among authors: saiz ruiz j. Psychiatry Res. 2023 Jul;325:115249. doi: 10.1016/j.psychres.2023.115249. Epub 2023 May 9. Psychiatry Res. 2023. PMID: 37178502 Free article.
226 results